Figure 5

Recurrent inactivating rearrangements of RASSF8 in cancer. Identification of ASUN-RASSF8 in a lung adenocarcinoma tumor (upper panel) and RASSF8-MARS in the KPD osteosarcoma cell-line (lower panel). Schematic representation of the fusion transcripts and some of the transcriptome sequencing reads spanning the fusion point.